Schedule 13G ownership disclosure
AXXESS PHARMA INC.
Security class unavailable · CUSIP: 01989F109
Event date: 2022-01-11
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 9.9900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-22-001533
- Form type
- SC 13G
- Filer
- AXXESS PHARMA INC.
- CIK
- CIK 1103309
- Filed
- Jan 11, 2022
- Reporting period
- Jan 11, 2022
- Description
- Schedule 13G beneficial ownership